A heritage-rich one started nearly 50 years ago with a vision to facilitate access to trusted medicines in terms of efficacy and safety.
Dar Aldawa is a leading pharmaceutical company dedicated to serving patients and the medical community across the world.
Dar Aldawa aims to become the foremost pharmaceutical partner for key stakeholders keen on improving health outcomes, cost of care, and the well-being of patients and their caregivers.
The Board Of Directors 0f Dar Al-Dawa Company For Development And investment Pic. Is Honored To invite you To Attend The (Extraordinary-General Assembly Meeting, Which Will Be Held At (1 1:00 AM On Monday, April 8, 2024), Via Visual And Electronic Means, As Per The Approval Of The (Minister O industry Trade & Supply) For Holding 0f The Extraordinary General Assembly Meeting 0f The Company Through Visual And Electronic Means (200M). This Meeting Will Be Held To Consider The Matters Listed On The Agenda, Which Have Been Published On The Company/'s Website And The iCC01 Companies Control Department Web Site. Shareholders Are Kindly Requested To Register To Attend The Mentioned Meeting & Review The Documents Related To The-Meeting
Dar Aldawa is a
leading
pharmaceutical
company
dedicated to
serving patients,
healthcare
professionals
and payers
across the world.
Vision
Dar Aldawa aims to become the foremost pharmaceutical partner for key stakeholders keen on improving health outcomes, cost of care, and the well-being of patients and their caregivers.
